Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Who is moving to which position
Resolved 13 May 2026Incoming appointee
5 itemsScheduled Appointment Date24 June 2026. The changes in representative directors and officer appointments are scheduled to be decided at the 154th Annual General Meeting of Shareholders, scheduled for the same day, and at an extraordinary meeting of the Board of Directors to be held after the meeting.
Umeda Takahiro (梅田 隆宏)
Previous positionRepresentative Director, Executive Senior Vice President, responsible for Finance, Information Systems and the Nail Business
New positionRepresentative Director, Executive Vice President, CFO, responsible for Finance and the Nail Business
生年月日 Not disclosed
Yoshimoto Ryuichi (吉本 龍一)
Previous positionSenior Executive Officer, responsible for Research and Development, Technology and Marketing
New positionDirector, Senior Executive Officer, responsible for Research and Development, Technology and Marketing
生年月日 Not disclosed
Miyake Hiroyoshi (三宅 宏善)
Previous positionExecutive Officer, General Planning Department Manager
New positionDirector, Senior Executive Officer, responsible for Information Systems and General Affairs
生年月日 Not disclosed
Iizuka Kensuke (飯塚 健介)
Previous positionSenior Executive Officer and CFO of SYSMEX CORPORATION, responsible for Corporate Management and the Next-Generation Medical Business (current)
New positionOutside Director (part-time)
生年月日 5 March 1970
Ono Shingo (小野 真吾)
Previous positionExecutive Fellow and General Manager of the Oral Care Business Department, Life & Healthcare Solutions Business Sector, Mitsui Chemicals,Inc. (current)
New positionOutside Director (part-time)
生年月日 9 February 1976
Departing officer
6 itemsDate of departure24 June 2026
Negoro Noriyuki (根來 紀行)Next role stated
Former PositionRepresentative director and chairman
New position(Retirement)
Suzuki Motoichi (鈴木 基市)Next role stated
Former PositionOutside Director (part-time)
New position(Retirement)
Matsue Kaori (松江 香織)Next role stated
Former PositionOutside Director (part-time)
New position(Retirement)
Komatsu Shigeyuki (小松 繁幸)Next role stated
Former PositionFull-time Audit & Supervisory Board Member
New position(Retirement)
Murakami Kazuhiko (村上 和彦)Next role stated
Former PositionExecutive Vice President, responsible for Sales and International Operations
New position(Retirement)
Wakayama Takashi (若山 隆)Next role stated
Former PositionExecutive Officer, General Manager responsible for International Operations
New position(Retirement)
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Whether the incumbent will remain in office (whether they will retain their position)
None of the departing individuals will remain on the Board of Directors.
Shareholders’ meeting approvalRequired. The changes in representative directors and officer appointments are scheduled to be decided at the 154th Annual General Meeting of Shareholders, scheduled for 24 June 2026, and at an extraordinary meeting of the Board of Directors to be held after the meeting.
Reason for change
In light of the mandatory retirement age for directors stipulated in the Company's regulations, the changes are intended to refresh the management structure and facilitate generational succession. In addition, the positions of CEO, CFO and CSO will be newly established to strengthen the management execution structure by clarifying responsibility and authority for execution.
Details of organizational changes
The positions of CEO, CFO and CSO will be newly established.
| Item | Details |
|---|---|
| Resolution date | 13 May 2026 |
| Scheduled Appointment Date | 24 June 2026. The changes in representative directors and officer appointments are scheduled to be decided at the 154th Annual General Meeting of Shareholders, scheduled for the same day, and at an extraordinary meeting of the Board of Directors to be held after the meeting. |
| Date of departure | 24 June 2026 |
| Name of appointee | Umeda Takahiro (梅田 隆宏), Yoshimoto Ryuichi (吉本 龍一), Miyake Hiroyoshi (三宅 宏善), Iizuka Kensuke (飯塚 健介), Ono Shingo (小野 真吾) |
| Appointee's new position | Representative Director, Executive Vice President, CFO, responsible for Finance and the Nail Business, Director, Senior Executive Officer, responsible for Research and Development, Technology and Marketing, Director, Senior Executive Officer, responsible for Information Systems and General Affairs, Outside Director (part-time), Outside Director (part-time) |
| Appointee's previous position | Representative Director, Executive Senior Vice President, responsible for Finance, Information Systems and the Nail Business, Senior Executive Officer, responsible for Research and Development, Technology and Marketing, Executive Officer, General Planning Department Manager, Senior Executive Officer and CFO of SYSMEX CORPORATION, responsible for Corporate Management and the Next-Generation Medical Business (current), Executive Fellow and General Manager of the Oral Care Business Department, Life & Healthcare Solutions Business Sector, Mitsui Chemicals,Inc. (current) |
| Appointee's date of birth | Not disclosed, Not disclosed, Not disclosed, 5 March 1970, 9 February 1976 |
| Name of departing officer | Negoro Noriyuki (根來 紀行), Suzuki Motoichi (鈴木 基市), Matsue Kaori (松江 香織), Komatsu Shigeyuki (小松 繁幸), Murakami Kazuhiko (村上 和彦), Wakayama Takashi (若山 隆) |
| Former position of departing officer | Representative director and chairman, Outside Director (part-time), Outside Director (part-time), Full-time Audit & Supervisory Board Member, Executive Vice President, responsible for Sales and International Operations, Executive Officer, General Manager responsible for International Operations |
| New position of departing officer | (Retirement), (Retirement), (Retirement), (Retirement), (Retirement), (Retirement) |
| Whether the incumbent will remain in office | None of the departing individuals will remain on the Board of Directors. |
| Reason for change | In light of the mandatory retirement age for directors stipulated in the Company's regulations, the changes are intended to refresh the management structure and facilitate generational succession. In addition, the positions of CEO, CFO and CSO will be newly established to strengthen the management execution structure by clarifying responsibility and authority for execution. |
| Details of organizational changes | The positions of CEO, CFO and CSO will be newly established. |
| Subject to Approval by the General Meeting of Shareholders | Required. The changes in representative directors and officer appointments are scheduled to be decided at the 154th Annual General Meeting of Shareholders, scheduled for 24 June 2026, and at an extraordinary meeting of the Board of Directors to be held after the meeting. |
Items this document does not state (7)
Year the appointee joined the CompanyNumber of shares held by the appointeeReason for departureReasons for appointmentNumber of directors after the changeFiling as an independent officerChange in Corporate Governance Structure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In light of the mandatory retirement age for directors stipulated in the Company's regulations, the changes are intended to refresh the management structure and facilitate generational succession. In addition, the positions of CEO, CFO and CSO will be newly established to strengthen the management execution structure by clarifying responsibility and authority for execution.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.